Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hospital Medicine
•
General Hospital Medicine
What is your preferred first-line agent for VTE prophylaxis in hospitalized medical patients with adequate renal function?
Do you prefer heparin, enoxaparin, DOAC, or aspirin?
Answer from: at Community Practice
Lovenox. It can also be dose adjusted for poor renal clearance if needed; otherwise, Heparin.
Comments
at University of Colorado Anschutz Medical Center
DOACs, unless planned procedures to increase adher...
at Baylor University Medical Center
Although oral anticoagulation therapies would avoi...
15796
15802
Sign in or Register to read more
27512
Related Questions
Is it clinically necessary to provide supplemental oxygen to patients with mild, asymptomatic hypoxemia only during activity while they are recovering from an acute respiratory illness?
How do you rule out empyema in a small pleural effusion that is not amenable to thoracentesis?
How do you think about deferring VTE prophylaxis versus implementing non-pharmacologic methods when chemical prophylaxis is contraindicated?
Do you have any concerns about lower extremity compression (e.g., compression stockings, intermittent pneumatic compression, etc.) worsening ascites in a patient with portal hypertension?
What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
How do you decide if patients without contraindications should receive IV fluids during the pre-operative period if they are undergoing surgery during their hospitalization?
Do you always stop dexamethasone at discharge for patients admitted with COVID requiring respiratory support (as done in the RECOVERY trial), or are there situations in which you will prescribe it to complete a 10-day course?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
DOACs, unless planned procedures to increase adher...
Although oral anticoagulation therapies would avoi...